A Double‐Blind Comparison of Meptazinol with Pentazocine and Placebo in Cancer Pain
- 1 January 1978
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 18 (1) , 76-79
- https://doi.org/10.1002/j.1552-4604.1978.tb01563.x
Abstract
Two consecutive double-blind crossover single-administration trials [with humans] have shown that i.m. meptazinol, a new opioid-antagonist drug, is superior to placebo and equivalent to pentazocine in relieving chronic pain due to cancer.This publication has 4 references indexed in Scilit:
- A double-blind comparison between meptazinol (Wy 22811) and ‘Buscopan’ Compositum in renal colicCurrent Medical Research and Opinion, 1976
- Preliminary metabolic studies on the new analgesic meptazinol [letter].Published by Wiley ,1975
- Meptazinol (Wy 22811), a new analgesic: Preliminary pharmacokinetic dataCurrent Medical Research and Opinion, 1975
- Clinical pharmacology of analgesics: 1. A method of assaying analgesic effectClinical Pharmacology & Therapeutics, 1960